Conference
Results of a randomized phase II study of two schedules of bryostatin-I in patients with malignant melanoma: experience with the multivariate stopping rule
Authors
Belanger K; Tozer R; Burdette-Radoux S; Davis M; Lohmann R; Zee B; Wainman N; Seymour L
Volume
35
Publisher
Elsevier
Publication Date
September 1, 1999
DOI
10.1016/s0959-8049(99)81937-6
Conference proceedings
European Journal of Cancer
ISSN
0959-8049